PGEN News and Press, Precigen Inc. From 11/13/25

2025-11-13 16:09:36 ET More on Precigen The Outlook For Precigen Precigen, Inc. (PGEN) H.C. Wainwright Virtual Fireside Chat Transcript Precigen Q3 Earnings Preview Precigen announces up to $125M non-dilutive financing Seeking Alpha’s Quant Rat...

2025-11-13 10:00:00 ET Read the full article on Seeking Alpha For further details see: Here are the major earnings after the close Thursday

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

2025-11-12 11:09:33 ET More on Precigen The Outlook For Precigen Precigen, Inc. (PGEN) H.C. Wainwright Virtual Fireside Chat Transcript Precigen: This Billion-Dollar Approval Is Still Undervalued Precigen announces up to $125M non-dilutive financing P...

Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 PR Newswire GERMANTOWN, Md. , Nov. 6, 2025 /PRNewswire/ --  Precigen, Inc.  (Nasdaq: PGEN), a biopharmaceutical company specializing in the advancement of innovativ...

2025-10-16 17:26:00 ET The following segment was excerpted from Patient Opportunity Equity Strategy Q3 2025 Portfolio Activity And Attribution ... Read the full article on Seeking Alpha For further details see: Patient Capital's Q3 2025 Top Contributors And Detractors

Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis PR Newswire 15 out of 18 complete responders (83%) demonstrat...

2025-09-23 18:18:23 ET Shares of gene and cell therapy concern Precigen, Inc. ( PGEN ) have rallied substantially since its recurrent respiratory papillomatosis therapy Papzimeos received full approval from the FDA on August 14th. The first-ever approval for the indication will ...

2025-09-07 08:23:00 ET Investors in search of stocks that can produce dramatic gains in a short time frame will want to turn their heads toward the healthcare sector. A handful of stocks in the space more than doubled in price recently. Shares of Precigen (NASDAQ: PGEN) and ...

2025-09-03 07:45:17 ET More on Precigen Precigen, Inc. - Special Call Precigen: This Billion-Dollar Approval Is Still Undervalued Precigen: August Is Pivotal For This Biotech Innovator Precigen surges on FDA approval for immunotherapy Seeking Alpha&#x...